EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent and anticipated novel drug approvals (1Q 2025 through 4Q 2025)

Matthew H Rim, Brittany L Karas, Farah Barada, Mary Golf, Vishal Prakash, Andrew M Levitsky

American Journal of Health-System Pharmacy · 2025

DOI: 10.1093/ajhp/zxaf030 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Health-System Pharmacy, 2025. Verfasst von Matthew H Rim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Northwestern Medicine, Chicago, IL, USA. Hauptthemen laut MEDLINE: Drug Approval, Pharmacists. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Health-system pharmacists play a crucial role in monitoring the pharmaceutical pipeline to manage formularies, allocate resources, and optimize clinical programs for new therapies. This article aims to support pharmacists by providing updates on new and anticipated novel drug approvals. Summary Selected drug approvals anticipated in the 12-month period covering each quarter of 2025 are reviewed. The analysis emphasizes drugs expected to have significant clinical and financial impact in hospitals and clinics, as selected from 60 novel drugs awaiting US Food and Drug Administration approval. This year’s pipeline features gene and cell therapies for rare diseases, agents for neurological disorders, and several novel treatments for cancers and various disease states.

Conclusion

Novel therapies continue to strengthen the current drug pipeline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug ApprovalPharmacistsHumansUnited StatesUnited States Food and Drug AdministrationProfessional Role

Stichwörter der Autor:innen

Food and Drug Administration drug approvalclinical trialsdrug approval processinvestigational drugsmedication developmentnew drug approvals

Autor:innen und Institutionen

  • Northwestern Medicine, Chicago, IL, USA.
  • IPD Analytics, Aventura, FL, USA.

Zitieren

APA

Rim, M. H., Karas, B. L., Barada, F., Golf, M., Prakash, V., & Levitsky, A. M. (2025). Recent and anticipated novel drug approvals (1Q 2025 through 4Q 2025). American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxaf030

Vancouver

Rim MH, Karas BL, Barada F, Golf M, Prakash V, Levitsky AM. Recent and anticipated novel drug approvals (1Q 2025 through 4Q 2025). American Journal of Health-System Pharmacy. 2025. doi:10.1093/ajhp/zxaf030

BibTeX
@article{Rim2025,
  author = {Rim, Matthew H and Karas, Brittany L and Barada, Farah and Golf, Mary and Prakash, Vishal and Levitsky, Andrew M},
  title = {Recent and anticipated novel drug approvals (1Q 2025 through 4Q 2025)},
  journal = {American Journal of Health-System Pharmacy},
  year = {2025},
  doi = {10.1093/ajhp/zxaf030}
}
Kostenlos starten →